XOMAO News
XOMA Corp Announces $0.5234 Dividend for 8.375% DP Preferred Shares
XOMA Completes Acquisition of Mural Oncology at $2.035 per Share
XOMA Royalty Announces Financial Results for Q3 and Year-to-Date 2025, Along with Recent Business Milestones
XOMA Royalty Prolongs Tender Offer to Purchase LAVA Therapeutics N.V.
XOMA Royalty Enters into Agreement to Acquire LAVA Therapeutics for Between $1.16 and $1.24 Per Share in Cash, Plus a Contingent Value Right
HilleVax Enters into a Definitive Agreement to be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value Right
Turnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value Right
XOMA Royalty Declares Quarterly Preferred Stock Dividends
XOMAO Events
No data
XOMAO Monitor News
No data
XOMAO Earnings Analysis